Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2018
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 1
2021 1
2022 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Wang T, Zhou Q, Zeng H, Zhang H, Liu Z, Shao J, Wang Z, Xiong Y, Wang J, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Chang Y, Wang X, Xu J. Wang T, et al. Cancer Immunol Immunother. 2020 Sep;69(9):1855-1867. doi: 10.1007/s00262-020-02583-y. Epub 2020 May 4. Cancer Immunol Immunother. 2020. PMID: 32367308 Free PMC article.
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y, Chang Y, Wang Z, Chen L, Kong Y, Zhang P, Liu Z, Zhou Q, Chen Y, Wang J, Bai Q, Xia Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Wang Y, Xu J, Zhang W. Qi Y, et al. Cancer Immunol Immunother. 2019 Dec;68(12):2067-2080. doi: 10.1007/s00262-019-02429-2. Epub 2019 Nov 12. Cancer Immunol Immunother. 2019. PMID: 31720813 Free PMC article.